December 2 (SeeNews) - Bulgarian pharmaceuticals maker Sopharma [BUL:SFA] said its consolidated net profit after minority interest went down to 64.4 million levs ($34.8 million/32.9 million euro) in January-September from 77.7 million levs in the same period of 2023.